GXFC3 (Combivir 150 mg / 300 mg)
Generic Name: lamivudine/zidovudine
Pill imprint GXFC3 has been identified as Combivir 150 mg / 300 mg.
Combivir is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Combivir 150 mg / 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GXFC3 (Combivir 150 mg / 300 mg)
Combivir
- Generic Name:
- lamivudine/zidovudine
- Imprint:
-
GXFC3
- Strength:
- 150 mg / 300 mg
- Color:
- White
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0595
- Inactive Ingredients:
- silicon dioxide colloidal
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
More resources
Combivir is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
